Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-30T19:59:13.648Z Has data issue: false hasContentIssue false

Personality profiles of patients with alcohol and drug misuse in a Nigerian treatment facility

Published online by Cambridge University Press:  02 January 2018

T. A. Adamson
Affiliation:
Drug Addiction Treatment Education and Research unit (DATER), Neuropsychiatric Hospital, Abeokuta
P. O. Onifade
Affiliation:
DATER, Neuropsychiatric Hospital, Abeokuta, Nigeria, email oniffpo@yahoo.com
O. I. Ibikunle
Affiliation:
DATER
E. B. Somoye
Affiliation:
DATER
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Drug dependence treatment in Nigeria is at an early stage of development. The first ‘stand alone’ drug dependence treatment in-patient unit in Nigeria, the Drug Addiction Treatment Education and Research (DATER) unit, Aro, Abeokuta, Nigeria, was established in 1983. Prior to this, patients with drug dependence received care along with other patients in psychiatric wards and traditional healing homes (United Nations International Drug Control Programme, 1998). Currently, there is no national body in Nigeria actively involved in regulating or facilitating good practice in drug dependence treatment.

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © The Royal College of Psychiatrists 2010

References

Adamson, T. A., Onifade, P. O. & Ogunwale, A. (2010) Trends in socio-demographic and drug abuse variables in patients with alcohol and drug use disorders in a Nigerian treatment facility. West African Journal of Medicine, 29, 1218.Google Scholar
Ball, S. A. (1998) Manualised treatment for substance abusers with personality disorders: dual focus schema therapy. Addictive Behaviors, 23, 883891.CrossRefGoogle Scholar
Butcher, J. N., Graham, J. R., Ben-Porath, Y. S., et al (2001) MMPI-2 Manual for Administration, Scoring and Interpretation. University of Minnesota Press.Google Scholar
Craig, R. J. (1984) A comparison of MMPI profiles of heroin addicts based on multiple methods of classification. Journal of Personality Assessment, 48, 115120.CrossRefGoogle ScholarPubMed
Graham, R. J. (1993) MMPI-2: Assessing Personality and Psychopathology (2nd edn). Oxford University Press.Google Scholar
Makanjuola, J. D. A. (1986) The Aro drug addiction research and treatment centre: a first report. British Journal of Addiction, 81, 809814.CrossRefGoogle ScholarPubMed
National Institute on Drug Abuse (1999) Principles of Drug Addiction Treatment: A Research-Based Guide (2nd edn). NIH Publication No. 99-4180. Available at http://www.drugabuse.gov/PDF/PODAT/PODAT.pdf (accessed May 2010).Google Scholar
Steffenhagen, R. A. (1980) Self-esteem theory of drug abuse. In Theories on Drug Abuse: Selected Contemporary Perspectives (eds Lettieri, D. J., Sayers, M. & Pearson, H. W.), pp. 96–95. National Institute on Drug Abuse. Available at http://archives.drugabuse.gov/pdf/monographs/30.pdf (accessed May 2010).Google Scholar
United Nations International Drug Control Programme (1998) Report of the Rapid Situation Assessment of Drug Abuse in Nigeria. UNDCP.Google Scholar
Verheul, R. (2001) Co-morbidity of personality disorders in individuals with substance use disorders. European Psychiatry, 16, 274282.CrossRefGoogle ScholarPubMed
World Health Organization (1992) International Classification of Diseases (10th revision) (ICD–10). WHO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.